Skip to content

Novel Robotic Prostatectomy Technique for Early Urinary Continence

Prostate Cancer

The goal of this a single arm prospective study is to evaluating the 3-month return of urinary continence outcomes of patients undergoing the transvesical retzius sparing robotic radical prostatectomy (TRS-RALP) for standard of care surgical prostate removal for treatment of prostate cancer.

The main question it aims: To have patients respond to questionnaires to collect exploratory data on patient's quality of life (QoL; EuroQol-5 Dimension 5-Level \[EQ-5D-5L\] and prostate cancer related urinary, bowel, and sexual function questionnaires (Expanded Prostate cancer Index Composite for Clinical Practice (EPIC-CP), at their standard of care perioperative visits at baseline and at 4 weeks, 3- and 6-months post operatively.

null

Participation Requirements

  • Sex:

    MALE

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* Patients undergoing standard of care robotic radical prostatectomy for localized prostate cancer

Exclusion Criteria:

* Patients with previous pelvic surgery
* Patients with previous pelvic radiotherapy
* Patient with previous focal therapy for prostate cancer
* Patients aged \< 18 years at diagnosis
* Legally incapable patients
* Patients who are unable to receive information about the study in a language they understand
* Patients who are unable to complete questionnaires and have no companion to help complete them
* Patients undergoing a concomitant cancer surgery

Study Location

Jewish General Hospital
Jewish General Hospital
Montréal, Quebec
Canada

Contact Study Team

Backup Contact

Oleg Loutochin

[email protected]
514-340-8222
Primary Contact

Victor McPherson, MD

[email protected]
514-340-8222
Study Sponsored By
Sir Mortimer B. Davis - Jewish General Hospital
Participants Required
More Information
Study ID: NCT06237114